New Synthetic Drugs: The Hidden Danger of Gummies, Puffs, and PTC
Share
New Synthetic Drugs, also called NPS, include psychoactive substances created or diverted to reproduce the effects of known drugs such as cannabis, cocaine, MDMA, amphetamines, opioids, or ketamine.
Their main danger lies in their rapid evolution: variable composition, unpredictable dosages, deceptive forms, online circulation, and difficulty of detection by standard tests. For families, schools, health professionals, companies, and prevention actors, understanding these substances becomes essential.
Why do NPS worry prevention professionals so much?
NPS are not a single drug but a set of very different chemical families. Some aim to mimic cannabis, others stimulants, opioids, or dissociatives. This diversity makes their identification complex.
According to Drogues Info Service, new synthetic products are psychoactive substances that attempt to reproduce the effects of existing illicit drugs. OFDT and the European Union Agency for Drugs also highlight the rapid market evolution, with the emergence of synthetic cannabinoids, cathinones, synthetic opioids, and nitazenes.
One product can hide another
The user may think they are buying cannabis, cocaine, a medication, or another substance, while the product contains a more potent or different NPS.
A high risk of poisoning
Some active substances at very low doses can cause severe effects, especially in cases of mixing, ignorance of dosage, or polyconsumption.
Standard tests have limitations
Many standard tests do not detect new molecules. Therefore, devices adapted to the targeted substance families must be used.
Key point: a negative test on a standard panel does not necessarily mean the absence of a substance. It all depends on the families targeted by the test, the molecule consumed, the detection window, and the context.
The 4 major families of new synthetic drugs to know
To better understand the risks, it is useful to classify NPS into major categories. This mapping does not replace a toxicological analysis, but it helps identify the main danger profiles.
The specific case of Xylazine: a substance to watch
Xylazine, sometimes called “Tranq” in certain North American contexts, is a veterinary sedative that can be found as an adulterant in some products. It does not operate exactly through the same mechanism as opioids, but it is often mentioned in health alerts due to its possible association with opioid products or other substances.
Note: Xylazine can increase the risks of sedation, discomfort, loss of consciousness, or serious complications. Its presence in a product consumed unknowingly can make the situation particularly dangerous.
Why are young people and families particularly exposed?
The danger of NPS also lies in their presentation. Some substances circulate in forms that seem ordinary: e-liquids, candies, gummies, powders, crystals, tablets, fake medicines, or mixtures presented as “legal,” “natural,” or “research chemicals.”
Deceptive forms
A product may be presented as CBD, an e-liquid, candy, a supplement, or a medicine while containing a powerful psychoactive substance.
Circulation via the Internet and social networks
NPS can circulate via websites, messaging apps, social networks, or informal channels, often with misleading information about their real composition.
Risk normalization
Street names, colorful packaging, or edible forms can make it easy to forget that these substances can cause severe poisonings.
Sometimes complex detection
Standard panels do not always cover emerging molecules. Effective screening requires choosing a test adapted to the substances sought.
Glossary 2026: molecules, street names, and detection solutions
Street names evolve quickly and vary by country, environment, and sales channels. This glossary aims to provide reference points without claiming to cover all existing names.
Targeted detection of new synthetic drugs: the Drugdiag® 6T test
Classic urine tests do not always cover new synthetic drugs. To meet this need, AMA Prévention offers the Drugdiag® 6T urine test, designed to target several specific families: synthetic cannabinoids, synthetic cathinones, MDPV, and Xylazine.
This solution is especially useful for prevention, self-monitoring, support, or targeted screening when classic substances do not fully explain a situation.
How to react in case of doubt or malaise?
When facing suspected use, poisoning, or chemical submission, avoid hasty conclusions. The priority is the person's safety, medical guidance if necessary, and preserving useful information.
Help and emergency resources
Medical emergency: in case of unusual behavior, malaise, loss of consciousness, seizures, respiratory distress, or suspected poisoning, immediately contact 15, 112, or emergency services.
Drogues Info Service: information, listening, and guidance at 0 800 23 13 13, a free and anonymous service.
Product analysis: the SINTES system and certain analysis networks allow, depending on the situation, to document the composition of suspicious products. Professionals can direct you to the appropriate services.
In case of severe symptoms, do not try to identify the substance first.
The priority is to call for help. A screening test can assist in prevention or guidance efforts, but it never replaces urgent medical care.
Frequently asked questions about new synthetic drugs
What is a new synthetic drug?
A new synthetic drug, or NPS, is a psychoactive substance created or diverted to mimic the effects of known drugs such as cannabis, cocaine, MDMA, amphetamines, opioids, or ketamine.
Are NPS detected by standard urine tests?
Not always. It depends on the test used and the families of substances sought. Some standard panels do not target synthetic cannabinoids, cathinones, Xylazine, or other emerging substances.
Does the Drugdiag® 6T test detect new synthetic drugs?
The Drugdiag® 6T test is designed to target several specific families of synthetic drugs, including certain families of synthetic cannabinoids, synthetic cathinones, MDPV, and Xylazine, depending on the device's characteristics.
Why are synthetic cannabinoids more dangerous than classic cannabis?
Synthetic cannabinoids can have very variable potency, composition, and duration of action. This unpredictability increases the risk of discomfort, hallucinations, convulsions, heart problems, or severe poisoning.
What to do in case of suspected poisoning?
In case of discomfort, loss of consciousness, respiratory distress, extreme agitation, or convulsions, contact 15 or 112 immediately. Medical care is a priority.
Conclusion: faced with NPS, information and targeted screening become essential
New synthetic drugs change the rules of prevention. They circulate in various forms, with multiple names, uncertain dosages, and sometimes very serious effects. Their detection therefore requires a more precise approach than a simple standard test.
For parents, healthcare professionals, companies, schools, associations, and field actors, the challenge is twofold: better inform and have tools adapted to the substances actually sought.
AMA Prévention supports this approach with targeted screening solutions, prevention materials, and a responsible approach to emerging risks.
Useful sources and references
Sources used for general verification: Drogues Info Service, OFDT, EUDA / European Union Agency for Drugs, SINTES system. This article is written for informational purposes and does not replace individualized medical, toxicological, or legal advice. In case of emergency or severe symptoms, call 15 or 112 immediately.
